ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

An Intrepid Solution for Transfemoral Treatment of Mitral Regurgitation.

A 5-part roundtable discussion with experts.

Margaret McEntegart discusses with Ziad Ali the genesis for his recent eccentric publication as well as Ali andDarshan Doshi’s experience with the new Shockwave C2+ catheter and how they manage the 120 pulses across lesions with heterogeneous calcium that includes concentric, eccentric and nodular calcium.